St. Jude Medical (STJ) 8-K Results of Operations and Financial Condition

Exhibit 99.1

Pacemakers Ventricular Assist Devices Atrial Fibrillation ($1.1B) Atrial Fibrillation ($1.1B) Structural Heart ($0.6B) Vascular ($0.7B) PCI Optimization Vascular Closure Other Vascular Cardiac Rhythm Mgmt. (CRM) Cardiovascular PRODUCT CATEGORY REALIGNMENT Comparable PriorComparable New ICD Systems ($1.6B)Traditional CRM ($1.6B) ICDsICDs CRT-DPacemakers Pacemaker Systems ($0.9B)Heart Failure ($1.5B) Cardiac Resynchronization Therapy CRT-P CardioMEMS AF Access, Diagnostic & Ablation AF Access, Diagnostic & Ablation Left Atrial Appendage Occlusion Left Atrial Appendage Occlusion Heart Valves PFO Closure, Other Structural HeartCardiovascular ($1.2B) Heart Valves PFO Closure, Other Structural Heart CardioMEMS PCI Optimization Vascular Closure Other Vascular Percutaneous Heart Pumps Thoratec ($0.5B) Ventricular Assist Devices Percutaneous Heart Pumps Neuromodulation ($0.5B)Neuromodulation ($0.5B) All revenue numbers are 2015 estimated comparable reported revenue1